PRIMECAP MANAGEMENT CO/CA/ - Significant Ownership

Signature - Title
Jennifer Ottosen - Chief Compliance Officer
Location
Pasadena, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by PRIMECAP MANAGEMENT CO/CA/.

Significant Ownership of PRIMECAP MANAGEMENT CO/CA/

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RYTM Rhythm Pharmaceuticals, Inc. COM 10.69% $348M 6.57M PRIMECAP MANAGEMENT CO/CA/ Dec 31, 2024
LIVN LivaNova PLC COM 8.76% $187M 4.75M PRIMECAP MANAGEMENT CO/CA/ Dec 31, 2024
ACM AECOM COM 8.59% $1.06B 11.4M PRIMECAP MANAGEMENT CO/CA/ Dec 31, 2024
NTAP NetApp, Inc. COM 6.01% $1.07B 12.2M PRIMECAP MANAGEMENT CO/CA/ Dec 31, 2024
IMCR Immunocore Holdings plc - ADR ADR 5.33% $79.2M 2.67M PRIMECAP MANAGEMENT CO/CA/ Dec 31, 2024
FGEN FibroGen, Inc. COM 4.58% $1.43M 4.62M PRIMECAP MANAGEMENT CO/CA/ Dec 31, 2024

Schedules 13D/G Reported by PRIMECAP MANAGEMENT CO/CA/:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.